New cancer treatment options target cancer cell growth
Cancer cells are known to differ from healthy cells, including in their requirements for oxygen and nutrients, their blood supply, their rate of growth and in their ‘immune privileged’ position.
At present, leading research organisations are attempting to develop new medicines that may work on cancer cell metabolism and the ‘immune privileged’ position. However, these new medicines will take a long time to reach the market; they will have unknown side effects and are likely to be expensive.
Using existing, low cost, well tolerated medicines to treat cancer
The Care Oncology Clinic uses a mixture of established tolerable prescription medicines to treat patients with cancer. Data on patient outcomes will be reported.
The Care Oncology Clinic’s treatment is overseen by leading oncologists and evaluates the effectiveness and tolerability of mixtures of established prescription medicines. These medicines target cholesterol, glucose and glycolysis processes, which impact upon the metabolism of the cancer cells and the immune cells surrounding the cancer cells.